ADIPOQ and metabolic syndrome: Like fenofibrate, T. lutea reduced the atherogenic index of plasma, a metabolic syndrome and atherogenicity biomarker [17,18]; T. lutea also enhanced adiponectin, an adipocyte-secreted anti-inflammatory protein associated with lower inflammation and with increased antioxidant defenses [19,20].